EP. 1: Peer Exchange: The Importance of Improving DE&I in Clinical Trials
In the first part of this roundtable discussion, a panel of experts introduce themselves and highlight the challenges industry is seeing with underrepresentation of racial and ethnic groups in clinical trials.
EP. 2: Peer Exchange: Reaching Underrepresented Patient Populations
In the second part of this roundtable discussion, participants highlight best practices for reaching underrepresented populations and increasing their awareness of clinical trials.
EP. 3: Peer Exchange: Accountability for Implementing Diversity Action Plans
Participants touch on the different aspects of FDA's recent Diversity Action Plan guidance and how industry must be held accountable for implementing change.
EP. 4: Peer Exchange: Technology's Role in Achieving Greater DE&I in Clinical Trials
Industry experts discuss the use of decentralized technologies and the potential of artificial intelligence in reaching underrepresented patient populations.